Combined use of a novel cardioplegic formula with MPS® (Myocardial protection system) versus Cardioplexol ® (colloid solution with Procaine, magnesium and potassium) in isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation system).
Study Type
OBSERVATIONAL
Enrollment
211
use of a novel cardioplegic formula with MPS® (Myocardial protection system) versus Cardioplexol ® (colloid solution with Procaine, magnesium and potassium) in isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation system).
Klinik für Herzchirurgie, Universitätsspital Basel
Basel, Switzerland
Change in lab values for cardial biomarkers
cardial biomarkers measured are high sensitive troponin T (hs-TrT), Creatinkinase, (CK) Creatinkinase myocardial type (CK-MB)
Time frame: perioperative during hospital stay for CABG
mortality
death after coronary artery bypass grafting
Time frame: 30 days after CABG
need for intensive care unit
duration of stay at intensive care unit
Time frame: perioperative during hospital stay for CABG
dysrhythmia
rhythm disturbance after coronary artery bypass grafting
Time frame: perioperative during hospital stay for CABG
bleeding
bleeding complication after coronary artery bypass grafting
Time frame: perioperative during hospital stay for CABG
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.